Business Context and Reporting Period
Company: Evolv Technologies Holdings, Inc. (EVLV)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2025
Business Overview: Evolv is a security technology company providing AI-powered weapons detection systems (Evolv Express and Evolv eXpedite) primarily through subscription models to venues, schools, and public spaces. The company operates as a single reporting segment.
Key Financial Metrics (Six Months Ended June 30, 2025)
| Metric | Amount (in thousands) |
|---|---|
| Total Revenue | $64,551 |
| Gross Profit | $35,368 |
| Gross Margin | 54.8% |
| Operating Loss | $(31,882) |
| Net Loss | $(42,224) |
| Net Loss Per Share (Basic & Diluted) | $(0.26) |
| Cash and Cash Equivalents (as of June 30, 2025) | $36,942 |
| Net Cash Used in Operating Activities | $(426) |
| Accumulated Deficit | $(396,888) |
Material Changes vs. Prior Comparable Period
- Revenue Growth: Total revenue increased 36% year-over-year (from $47.4M to $64.6M), driven by a 32% increase in subscription revenue and a 110% increase in license fee and other revenue.
- Profitability Deterioration: Net loss widened significantly from $7.9M in the prior year period to $42.2M. This was primarily driven by a $46.7M swing in "Other (expense) income, net," which turned from a $36.4M gain in 2024 to a $10.3M loss in 2025 due to mark-to-market adjustments on contingent liabilities.
- Operating Expenses: Total operating expenses decreased 6% to $67.3M, reflecting cost-cutting measures (reduction in force) in R&D and Sales & Marketing, partially offset by a 25% increase in General and Administrative expenses due to legal and investigation-related fees.
- Restatement: The company restated financial statements for the three and six months ended June 30, 2024, due to revenue recognition errors involving extra-contractual terms. Prior period figures presented in this filing are restated.
Guidance, Outlook, Risks, and Unusual Items
- Restatement and Internal Controls: The company identified material weaknesses in internal controls over financial reporting, specifically regarding revenue recognition and the control environment. This led to the restatement of prior periods and ongoing remediation efforts.
- Legal Proceedings:
- Class Action Settlement: A settlement in principle of $15.0 million was reached on August 5, 2025, regarding securities class action litigation. The company estimates $14.0 million will be covered by D&O insurance, with a net $1.0 million loss accrued in Q2 2025.
- Regulatory Investigations: The company is cooperating with ongoing investigations by the SEC and previously settled with the FTC regarding marketing practices. The DOJ investigation was closed in August 2025.
- Liquidity and Financing: On July 29, 2025 (subsequent to the period end), the company entered into a $75.0 million Senior Secured Credit Facility with MidCap Financial Trust. Initial proceeds of $26.6 million were received. Management believes current cash plus borrowing availability is sufficient for at least 12 months.
- Unusual Items: Significant non-cash losses were recorded related to changes in the fair value of contingent earn-out liabilities, contingently issuable common stock, and public warrant liabilities. These items are highly volatile and dependent on the company's stock price.
Investor Verification Checklist
- Restatement Impact: Verify the specific adjustments made to prior period revenue and the timeline for the completion of the internal control remediation plan.
- Legal Exposure: Confirm the final terms of the $15.0 million class action settlement and the extent of insurance coverage for ongoing SEC/FTC matters.
- Debt Covenants: Review the financial covenants in the new $75.0 million credit facility (minimum ARR, EBITDA, and liquidity covenants) and assess the risk of default given current operating losses.
- Revenue Recognition: Scrutinize the new revenue recognition policies and controls implemented to prevent premature recognition, particularly regarding "extra-contractual terms."
- Volatility of Non-Operating Items: Monitor the fair value of warrant and earn-out liabilities, as fluctuations in stock price will continue to materially impact reported net income/loss.